Levemir, Blood Sugar Level Determination - 5 Pens
Description:
Levemir 100 iu/ml FlexPen is a long-acting basal insulin analog (insulin detemir) used for the management of diabetes mellitus in adults, adolescents, and children from 2 years of age. It is a prescription antidiabetic medicine from Novo Nordisk designed to provide steady, predictable blood sugar control over 24 hours when used as part of a comprehensive diabetes treatment plan. Each pack contains 5 pre-filled FlexPens for subcutaneous injection, allowing accurate dosing and convenient daily use for blood sugar level control and prevention of hyperglycemia-related complications.
Indications:
- Long-term treatment of diabetes mellitus type 1 in adults, adolescents, and children (as basal insulin in basal-bolus regimens).
- Treatment of diabetes mellitus type 2 in adults and adolescents when oral antidiabetic medicines alone are insufficient to achieve glycemic control.
- Helps maintain fasting and between-meal blood glucose levels within target range.
- Reduces the risk of hyperglycemia and related symptoms such as excessive thirst, frequent urination, fatigue, and blurred vision.
- Used in combination with rapid-acting insulin, oral antidiabetic drugs, or GLP-1 analogs as prescribed by a healthcare professional.
Active Ingredients / Key Components:
- Insulin detemir – 100 iu/ml (long-acting human insulin analog).
- Other excipients (such as glycerol, phenol, metacresol, zinc, sodium chloride, and water for injections) are present but exact full list and concentrations , please check the product leaflet or the manufacturer’s official website.
- Each FlexPen is a pre-filled, multi-dose insulin delivery device containing Levemir solution for injection. Exact volume per pen is not specified in the provided information.
Dosage & Administration / How to Use:
- Levemir is for subcutaneous injection only. Do not administer intravenously or via insulin infusion pumps.
- Recommended dose, timing, and injection schedule must be individualized by the treating physician based on blood glucose monitoring, type of diabetes, body weight, diet, and physical activity.
- Usually administered once or twice daily (evening or evening and morning) as basal insulin, as directed by your doctor.
- Inject into the subcutaneous tissue of the abdomen, thigh, upper arm, or buttock. Rotate injection sites within the same region to reduce the risk of lipodystrophy.
- Use the FlexPen exactly as instructed in the patient leaflet: attach a new sterile needle, perform a safety test, dial the prescribed dose, inject, and hold the needle under the skin for at least 6 seconds before removing.
- Can be used with or without food, but must be taken at the same time(s) each day as recommended by your healthcare provider.
- Never share your FlexPen or needles with anyone else to avoid cross-infection.
- Do not change your dose, insulin type, or injection schedule without consulting your doctor.
Clinical Benefits:
- Provides long-acting, stable basal insulin coverage to help maintain blood sugar levels within target range throughout the day and night.
- Reduces the risk of hyperglycemia and long-term diabetes complications affecting eyes, kidneys, nerves, and cardiovascular system when used as part of a complete diabetes management plan.
- Offers a more predictable glucose-lowering profile compared to NPH insulin, helping reduce blood sugar variability.
- Convenient pre-filled FlexPen device allows accurate dosing, easier handling, and improved adherence to insulin therapy.
Warnings & Contraindications:
- Contraindicated in patients with known hypersensitivity to insulin detemir or any of the excipients.
- Do not use during episodes of hypoglycemia (low blood sugar).
- Use with caution in patients with renal or hepatic impairment; dose adjustment and close monitoring may be required.
- Hypoglycemia is the most common risk with insulin therapy. Monitor blood glucose regularly and recognize signs such as sweating, tremor, palpitations, hunger, confusion, or headache.
- Consult your doctor before use if pregnant, planning pregnancy, or breastfeeding; insulin requirements may change and close medical supervision is essential.
- Inform your doctor about all medications you are taking, including oral antidiabetics, beta-blockers, ACE inhibitors, steroids, and others, as they may affect blood glucose levels.
- Alcohol consumption may enhance or reduce the blood glucose-lowering effect of insulin; use with caution.
- Use with caution when driving or operating machinery, especially if you experience frequent hypoglycemia or reduced awareness of hypoglycemia.
- Keep out of reach of children.
- This product is a prescription medicine and must be used under medical supervision.
Side Effects:
- Common: Hypoglycemia (low blood sugar), injection site reactions (redness, swelling, itching, pain, bruising), lipodystrophy (thickening or thinning of the skin) at injection sites.
- Uncommon: Edema (swelling due to fluid retention), weight gain related to improved metabolic control.
- Rare but serious: Severe allergic reactions including generalized rash, difficulty breathing, rapid heartbeat, or swelling of face, tongue, or throat. Seek immediate medical attention if these occur.
- Contact your doctor if you experience persistent or severe side effects, or if your blood sugar remains uncontrolled.
Storage Instructions:
Store unopened Levemir FlexPens in a refrigerator at 2–8°c. Do not freeze and do not place near the freezer compartment or cooling element. Once in use, the FlexPen may be kept at room temperature (below 30°c) for a limited period as specified in the official leaflet; keep away from direct heat and sunlight. Always keep the pen cap on when not in use. Do not use if the solution is not clear and colorless. Keep container out of reach of children.
Specifications:
- Product type: Long-acting insulin analog for subcutaneous injection.
- Strength: 100 iu/ml insulin detemir.
- Form: Pre-filled multi-dose FlexPen (solution for injection).
- Pack size: 5 FlexPens per pack (exact ml per pen not specified in the provided information).
- Route of administration: Subcutaneous.
Disclaimer: All pharmacy products are intended for general use only and do not replace professional medical advice, diagnosis, or treatment. Always consult a healthcare provider before use. Results may vary, and no specific outcomes are guaranteed. Products are not intended to diagnose, treat, cure, or prevent any disease unless stated. Follow label instructions carefully, as misuse may cause adverse effects. Compliance with local laws is the customer’s responsibility.
